GMP - Three letters with many interpretations: Protection of patients or killing the clinical and research applications of PET?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 4, 2008, Pages 693-694

  Långström, Bengt ^a   Hartvig, Per ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT;

CLINICAL EVALUATION; CLINICAL RESEARCH; DIAGNOSTIC IMAGING; DRUG INDUSTRY; DRUG MANUFACTURE; EDITORIAL; EXPERIMENTAL MEDICINE; GOOD MANUFACTURING PRACTICE; MEDICAL DOCUMENTATION; MEDICAL PERSONNEL; MOLECULAR IMAGING; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; QUALITY CONTROL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; TECHNOLOGY;

DRUG INDUSTRY; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 40949132607     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0657-1     Document Type: Editorial

References (0)